Build Your Comparison

Side-by-side financial analysis
VET logo
VET
CVE logo
CVE
Try popular comparisons:

Stock Comparison

VET vs CVE

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
VET
Vermilion Energy Inc.

Oil & Gas Exploration & Production

EnergyNYSE • CA
Market Cap$1.71B
5Y Perf.+150.0%
CVE
Cenovus Energy Inc.

Oil & Gas Integrated

EnergyNYSE • CA
Market Cap$53.24B
5Y Perf.+505.4%

VET vs CVE — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
VET logoVET
CVE logoCVE
IndustryOil & Gas Exploration & ProductionOil & Gas Integrated
Market Cap$1.71B$53.24B
Revenue (TTM)$1.81B$49.40B
Net Income (TTM)$-814M$4.64B
Gross Margin35.9%19.6%
Operating Margin20.2%14.0%
Forward P/E11.2x6.2x
Total Debt$1.30B$17.00B
Cash & Equiv.$19M$2.74B

VET vs CVELong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

VET
CVE
StockJun 20Jun 26Return
Vermilion Energy In… (VET)100250.0+150.0%
Cenovus Energy Inc. (CVE)100605.4+505.4%

Price return only. Dividends and distributions are not included.

Quick Verdict: VET vs CVE

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: CVE leads in 6 of 7 categories, making it the strongest pick for growth and revenue expansion and valuation and capital efficiency. Vermilion Energy Inc. is the stronger pick specifically for dividend income and shareholder returns. As sector peers, any of these can serve as alternatives in the same allocation.
🥇CVE emerged as the overall leader. Track its performance:
VET
Vermilion Energy Inc.
The Income Pick

VET is the clearest fit if your priority is income & stability and defensive.

  • Dividend streak 3 yrs, beta -0.18, yield 4.1%
  • Beta -0.18, yield 4.1%, current ratio 0.84x
  • 4.1% yield, 3-year raise streak, vs CVE's 2.0%
Best for: income & stability and defensive
CVE
Cenovus Energy Inc.
The Growth Play

CVE carries the broadest edge in this set and is the clearest fit for growth exposure and long-term compounding.

  • Rev growth -14.0%, EPS growth 28.7%, 3Y rev CAGR -11.6%
  • 109.7% 10Y total return vs VET's -39.7%
  • Lower volatility, beta 0.08, Low D/E 53.8%, current ratio 1.57x
Best for: growth exposure and long-term compounding
See the full category breakdown
CategoryWinnerWhy
GrowthCVE logoCVE-14.0% revenue growth vs VET's -15.0%
ValueCVE logoCVELower P/E (6.2x vs 11.2x)
Quality / MarginsCVE logoCVE9.4% margin vs VET's -44.9%
Stability / SafetyCVE logoCVELower D/E ratio (53.8% vs 58.6%)
DividendsVET logoVET4.1% yield, 3-year raise streak, vs CVE's 2.0%
Momentum (1Y)CVE logoCVE+100.1% vs VET's +45.6%
Efficiency (ROA)CVE logoCVE7.8% ROA vs VET's -13.8%, ROIC 7.9% vs 3.5%

VET vs CVE — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

VETVermilion Energy Inc.

Segment breakdown not available.

CVECenovus Energy Inc.
FY 2020
Upstream
100.0%$58M

VET vs CVE — Financial Metrics

Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLCVELAGGINGVET

Income & Cash Flow (Last 12 Months)

Evenly matched — VET and CVE each lead in 3 of 6 comparable metrics.

CVE is the larger business by revenue, generating $49.4B annually — 27.2x VET's $1.8B. CVE is the more profitable business, keeping 9.4% of every revenue dollar as net income compared to VET's -44.9%. On growth, CVE holds the edge at -12.8% YoY revenue growth, suggesting stronger near-term business momentum.

MetricVET logoVETVermilion Energy …CVE logoCVECenovus Energy In…
RevenueTrailing 12 months$1.8B$49.4B
EBITDAEarnings before interest/tax$1.2B$12.4B
Net IncomeAfter-tax profit-$814M$4.6B
Free Cash FlowCash after capex$301M$4.4B
Gross MarginGross profit ÷ Revenue+35.9%+19.6%
Operating MarginEBIT ÷ Revenue+20.2%+14.0%
Net MarginNet income ÷ Revenue-44.9%+9.4%
FCF MarginFCF ÷ Revenue+16.6%+8.8%
Rev. Growth (YoY)Latest quarter vs prior year-16.4%-12.8%
EPS Growth (YoY)Latest quarter vs prior year-10.9%+78.7%
Evenly matched — VET and CVE each lead in 3 of 6 comparable metrics.

Valuation Metrics

VET leads this category, winning 5 of 6 comparable metrics.

On an enterprise value basis, VET's 3.9x EV/EBITDA is more attractive than CVE's 9.0x.

MetricVET logoVETVermilion Energy …CVE logoCVECenovus Energy In…
Market CapShares × price$1.7B$53.2B
Enterprise ValueMkt cap + debt − cash$2.6B$63.4B
Trailing P/EPrice ÷ TTM EPS-3.68x18.38x
Forward P/EPrice ÷ next-FY EPS est.11.20x6.18x
PEG RatioP/E ÷ EPS growth rate
EV / EBITDAEnterprise value multiple3.92x9.04x
Price / SalesMarket cap ÷ Revenue1.35x1.50x
Price / BookPrice ÷ Book value/share1.08x2.28x
Price / FCFMarket cap ÷ FCF7.32x21.86x
VET leads this category, winning 5 of 6 comparable metrics.

Profitability & Efficiency

CVE leads this category, winning 7 of 9 comparable metrics.

CVE delivers a 15.2% return on equity — every $100 of shareholder capital generates $15 in annual profit, vs $-34 for VET. CVE carries lower financial leverage with a 0.54x debt-to-equity ratio, signaling a more conservative balance sheet compared to VET's 0.59x. On the Piotroski fundamental quality scale (0–9), CVE scores 6/9 vs VET's 3/9, reflecting solid financial health.

MetricVET logoVETVermilion Energy …CVE logoCVECenovus Energy In…
ROE (TTM)Return on equity-33.7%+15.2%
ROA (TTM)Return on assets-13.8%+7.8%
ROICReturn on invested capital+3.5%+7.9%
ROCEReturn on capital employed+3.3%+8.2%
Piotroski ScoreFundamental quality 0–936
Debt / EquityFinancial leverage0.59x0.54x
Net DebtTotal debt minus cash$1.3B$14.3B
Cash & Equiv.Liquid assets$19M$2.7B
Total DebtShort + long-term debt$1.3B$17.0B
Interest CoverageEBIT ÷ Interest expense2.53x11.80x
CVE leads this category, winning 7 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

CVE leads this category, winning 6 of 6 comparable metrics.

A $10,000 investment in CVE five years ago would be worth $30,275 today (with dividends reinvested), compared to $14,136 for VET. Over the past 12 months, CVE leads with a +100.1% total return vs VET's +45.6%. The 3-year compound annual growth rate (CAGR) favors CVE at 21.4% vs VET's 1.3% — a key indicator of consistent wealth creation.

MetricVET logoVETVermilion Energy …CVE logoCVECenovus Energy In…
YTD ReturnYear-to-date+31.7%+62.1%
1-Year ReturnPast 12 months+45.6%+100.1%
3-Year ReturnCumulative with dividends+4.0%+79.1%
5-Year ReturnCumulative with dividends+41.4%+202.8%
10-Year ReturnCumulative with dividends-39.7%+109.7%
CAGR (3Y)Annualised 3-year return+1.3%+21.4%
CVE leads this category, winning 6 of 6 comparable metrics.

Risk & Volatility

Evenly matched — VET and CVE each lead in 1 of 2 comparable metrics.

VET is the less volatile stock with a -0.18 beta — it tends to amplify market swings less than CVE's 0.08 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. CVE currently trades 88.2% from its 52-week high vs VET's 75.2% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricVET logoVETVermilion Energy …CVE logoCVECenovus Energy In…
Beta (5Y)Sensitivity to S&P 500-0.18x0.08x
52-Week HighHighest price in past year$14.82$32.07
52-Week LowLowest price in past year$7.00$13.47
% of 52W HighCurrent price vs 52-week peak+75.2%+88.2%
RSI (14)Momentum oscillator 0–10040.948.8
Avg Volume (50D)Average daily shares traded1.3M7.9M
Evenly matched — VET and CVE each lead in 1 of 2 comparable metrics.

Analyst Outlook

Evenly matched — VET and CVE each lead in 1 of 2 comparable metrics.

Wall Street rates VET as "Hold" and CVE as "Hold". Consensus price targets imply 2.6% upside for CVE (target: $29) vs -3.7% for VET (target: $11). For income investors, VET offers the higher dividend yield at 4.10% vs CVE's 1.98%.

MetricVET logoVETVermilion Energy …CVE logoCVECenovus Energy In…
Analyst RatingConsensus buy/hold/sellHoldHold
Price TargetConsensus 12-month target$10.74$29.00
# AnalystsCovering analysts1027
Dividend YieldAnnual dividend ÷ price+4.1%+2.0%
Dividend StreakConsecutive years of raises35
Dividend / ShareAnnual DPS$0.64$0.78
Buyback YieldShare repurchases ÷ mkt cap+1.5%+3.4%
Evenly matched — VET and CVE each lead in 1 of 2 comparable metrics.
Key Takeaway

CVE leads in 2 of 6 categories (Profitability & Efficiency, Total Returns). VET leads in 1 (Valuation Metrics). 3 tied.

Best OverallCenovus Energy Inc. (CVE)Leads 2 of 6 categories
Loading custom metrics...

VET vs CVE: Frequently Asked Questions

10 questions · data-driven answers · updated daily

01

Is VET or CVE a better buy right now?

For growth investors, Cenovus Energy Inc.

(CVE) is the stronger pick with -14. 0% revenue growth year-over-year, versus -15. 0% for Vermilion Energy Inc. (VET). Cenovus Energy Inc. (CVE) offers the better valuation at 18. 4x trailing P/E (6. 2x forward), making it the more compelling value choice. Analysts rate Vermilion Energy Inc. (VET) a "Hold" — based on 10 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — VET or CVE?

On forward P/E, Cenovus Energy Inc.

is actually cheaper at 6. 2x.

03

Which is the better long-term investment — VET or CVE?

Over the past 5 years, Cenovus Energy Inc.

(CVE) delivered a total return of +202. 8%, compared to +41. 4% for Vermilion Energy Inc. (VET). Over 10 years, the gap is even starker: CVE returned +109. 7% versus VET's -39. 7%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — VET or CVE?

By beta (market sensitivity over 5 years), Vermilion Energy Inc.

(VET) is the lower-risk stock at -0. 18β versus Cenovus Energy Inc. 's 0. 08β — meaning CVE is approximately -142% more volatile than VET relative to the S&P 500. On balance sheet safety, Cenovus Energy Inc. (CVE) carries a lower debt/equity ratio of 54% versus 59% for Vermilion Energy Inc. — giving it more financial flexibility in a downturn.

05

Which is growing faster — VET or CVE?

By revenue growth (latest reported year), Cenovus Energy Inc.

(CVE) is pulling ahead at -14. 0% versus -15. 0% for Vermilion Energy Inc. (VET). On earnings-per-share growth, the picture is similar: Cenovus Energy Inc. grew EPS 28. 7% year-over-year, compared to -1313. 3% for Vermilion Energy Inc.. Over a 3-year CAGR, CVE leads at -11. 6% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — VET or CVE?

Cenovus Energy Inc.

(CVE) is the more profitable company, earning 7. 9% net margin versus -37. 0% for Vermilion Energy Inc. — meaning it keeps 7. 9% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: VET leads at 9. 5% versus 8. 8% for CVE. At the gross margin level — before operating expenses — VET leads at 16. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is VET or CVE more undervalued right now?

On forward earnings alone, Cenovus Energy Inc.

(CVE) trades at 6. 2x forward P/E versus 11. 2x for Vermilion Energy Inc. — 5. 0x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for CVE: 2. 6% to $29. 00.

08

Which pays a better dividend — VET or CVE?

All stocks in this comparison pay dividends.

Vermilion Energy Inc. (VET) offers the highest yield at 4. 1%, versus 2. 0% for Cenovus Energy Inc. (CVE).

09

Is VET or CVE better for a retirement portfolio?

For long-horizon retirement investors, Vermilion Energy Inc.

(VET) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0. 18), 4. 1% yield). Both have compounded well over 10 years (VET: -39. 7%, CVE: +109. 7%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between VET and CVE?

Both stocks operate in the Energy sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: VET is a small-cap income-oriented stock; CVE is a mid-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.